LINC00294 promotes proliferation, invasion, and migration of breast cancer cells via AKT/mTOR/HIF-1α pathway
Basic Medicine|更新时间:2026-01-09
|
LINC00294 promotes proliferation, invasion, and migration of breast cancer cells via AKT/mTOR/HIF-1α pathway
Journal of Army Medical UniversityVol. 45, Issue 18, Pages: 1927-1936(2023)
作者机构:
400010 重庆,重庆医科大学附属第二医院乳腺甲状腺外科
作者简介:
基金信息:
the "Kuanren Elite" Backbone Talent Project of the Second Affiliated Hospital of Chongqing Medical University(KY2019G016);the Wu Jieping Medical Foundation(320.6750.2021-10-86)
Ting YANG, Tingrui WANG, Shanshan HAN, et al. LINC00294 promotes proliferation, invasion, and migration of breast cancer cells via AKT/mTOR/HIF-1α pathway[J]. Journal of Army Medical University, 2023, 45(18): 1927-1936.
DOI:
Ting YANG, Tingrui WANG, Shanshan HAN, et al. LINC00294 promotes proliferation, invasion, and migration of breast cancer cells via AKT/mTOR/HIF-1α pathway[J]. Journal of Army Medical University, 2023, 45(18): 1927-1936. DOI: 10.16016/j.2097-0927.202303100.
LINC00294 promotes proliferation, invasion, and migration of breast cancer cells via AKT/mTOR/HIF-1α pathway
To explore the changes in the expression of long non-coding RNA (LncRNA) LINC00294 in breast cancer tissues and cells
and investigate its effects and the possible mechanisms on the biological properties of breast cancer cells.
Methods
2
The differentially expressed genes (DEGs) were analyzed using transcriptome sequencing data from 41 breast cancer tissues and 11 para-cancerous tissues from the Gene Expression Omnibus (GEO) database (GSE45827). Then qRT-PCR assay was used to measure the expression of LINC00294 in 20 pairs of breast cancer and para-cancerous tissues from the breast cancer patients diagnosed in our department
as well as in the normal human breast epithelial MCF-10A cells and the human breast cancer cell lines MCF-7
K-BR-3 and MDA-MB-231. After MCF-7 cells were transfected with lentiviral vector of si-LINC to interfere LINC00294 expression
CCK-8 assay was used to detect cell proliferation
flow cytometry and Western blotting were employed to measure cell apoptosis and expression of related proteins
cell scratch assay and Transwell assay were applied to observe cell migration and invasion. Then
the effect of interference with LINC00294 on tumor growth in nude mice model of
in situ
subcutaneous tumorigenesis was observed. The expression of AKT/mTOR pathway-related proteins p-mTOR
mTOR
p-AKT
AKT
and its downstream target molecule HIF-1
α
was detected by Western blotting.
Results
2
LncRNA LINC00294 was screened out as a DEG in breast cancer tissues from the GEO database. It was also highly expressed in breast cancer tissues and MCF-7
SK-BR-3 and MDA-MB-231 cells (
P
<
0.05). Interference of LINC00294 resulted in reduced proliferation
enhanced expression of apoptosis-related proteins
and decreased invasion and migration abilities in MCF-7 cells (
P
<
0.05). The expression of LINC00294 was inhibited by HIF-1
α
interference (
P
<
0.05)
and LINC00294 interference decreased the expression of p-AKT
p-mTOR
mTOR and its downstream target molecule HIF-1
α
in the AKT/mTOR signaling pathway (
P
<
0.05).
Conclusion
2
High expression of LINC00294 in breast cancer may affect the proliferation
invasion
and migration of breast cancer through the AKT/mTOR/HIF-1
α
signaling pathway
and LINC00294 may be closely associated with the pathogenesis of breast cancer.
关键词
Keywords
references
SUNG H, FERLAY J, SIEGEL R L, et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
WANG J, TAN L R, YU X T, et al . LncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m 6 A reader YTHDC2[J ] . Mol Cancer, 2022, 21(1): 229. DOI: 10.1186/s12943-022-01705-7..
LUO Y, FANG X Y, XIE W J, et al . Long non-coding RNA LINC02163 is up-regulated and promotes cell migration and invasion in hepatocellular carcinoma[J ] . J Third Mil Med Univ, 2020, 42(1): 81-87. DOI: 10.16016/j.1000-5404.201907251.
CAI H Z, XU H F, LU H C, et al . LncRNA SNHG1 facilitates tumor proliferation and represses apoptosis by regulating PPARγ ubiquitination in bladder cancer[J ] . Cancers, 2022, 14(19): 4740. DOI: 10.3390/cancers14194740.
FAN C N, WANG Q, KUIPERS T B, et al . LncRNA LITATS1 suppresses TGF-β-induced EMT and cancer cell plasticity by potentiating TβRI degradation[J ] . EMBO J, 2023, 42(10): e112806. DOI: 10.15252/embj.2022112806.
PAN Y H, LU X X, SHU G N, et al . Extracellular vesicle-mediated transfer of LncRNA IGFL2-AS1 confers sunitinib resistance in renal cell carcinoma[J ] .Cancer Res, 2023, 83(1): 103-116. DOI: 10.1158/0008-5472.CAN-21-3432.
ZHANG C X, JIFU E, YU E D. LncRNA CASC21 induces HGH1 to mediate colorectal cancer cell proliferation, migration, EMT and stemness[J]. RNA Biol, 2021, 18(sup1): 369-381. DOI: 10.1080/15476286.2021.1950464.
ZHANG M, WANG N, SONG P, et al . LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1[J ] . Cell Prolif, 2020, 53(9): e12855. DOI: 10.1111/cpr.12855.
FENG C J, ZH AO Y, LI Y J, et al . LncRNA MALAT1 promotes lung cancer proliferation and gefitinib resistance by acting as a miR-200a sponge[J ] . Arch De Bronconeumología, 2019, 55(12): 627-633. DOI: 10.1016/j.arbres.2019.03.026.
YU Y, LV F, LIANG D, et al . HOTAIR may regulate proliferation, apoptosis, migration and invasion of MCF-7 cells through regulating the P53/Akt/JNK signaling pathway[J ] . Biomed Pharmacother, 2017, 90: 555-561. DOI: 10.1016/j.biopha.2017.03.054.
YANG X, CHEN L. Knock-down of long non-codingRNA GK-IT1 inhibits proliferation and promotes apoptosis in esophageal carcinoma cells[J]. J Third Mil Med Univ, 2021, 43(2): 146-155. DOI: 10.16016/j.1000-5404.202008083.
SLACK F J, CHINNAIYAN A M. The role of non-coding RNAs in oncology[J]. Cell, 2019, 179(5): 1033-1055. DOI: 10.1016/j.cell.2019.10.017.
LIU S Q, SUN Y, HOU Y X, et al . A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties[J ] . J Hematol Oncol, 2021, 14(1): 178. DOI: 10.1186/s13045-021-01194-z.
HU H T, ZHANG H Q, XING Y, et al . The lncRNA THOR interacts with and stabilizes hnRNPD to promote cell proliferation and metastasis in breast cancer[J ] . Oncogene, 2022, 41(49): 5298-5314. DOI: 10.1038/s41388-022-02495-4..
LUO A R, LAN X X, QIU Q Z, et al . LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation[J ] . Cell Death Dis, 2022, 13(11): 936. DOI: 10.1038/s41419-022-05359-7.
DONG X G, PI Q, YUEMAIERABOLA A, et al . Silencing LINC00294 restores mitochondrial function and inhibits apoptosis of glioma cells under hypoxia via the miR-21-5p/CASKIN1/cAMP axis[J ] . Oxidative Med Cell Longev, 2021, 2021: 1-21. DOI: 10.1155/2021/8240015..
ZHOU X K, LV L, ZHANG Z Y, et al . LINC00294 negatively modulates cell proliferation in glioma through a neurofilament medium-mediated pathway via interacting with miR-1278[J ] . J Gene Med, 2020, 22(10): e3235. DOI: 10.1002/jgm.3235..
QIU J N, ZHOU S L, CHENG W J, et al . LINC00294 induced by GRP78 promotes cervical cancer development by promoting cell cycle transition[J ] . Oncol Lett, 2020, 20(5): 1. DOI: 10.3892/ol.2020.12125.
XU J C, FENG H, MA L, et al . Bak kenolide-Ⅲa ameliorates lipopolysaccharide-induced inflammatory injury in human umbilical vein endothelial cells by upregulating LINC00294[J ] . Mol Med Rep, 2021, 23(5): 377. DOI: 10.3892/mmr.2021.12016.
UCARYILMAZ METIN C, OZCAN G. The HIF-1 α as a potent inducer of the hallmarks in gastric cancer[J ] . Cancers, 2022, 14(11): 2711. DOI: 10.3390/cancers14112711.
MULTHOFF G, VAUPEL P. Hypoxia compromises anti-cancer immune responses[M]// Oxygen Transport to Tissue XLI. Cham: Springer, 2020: 131-143.10.1007/978-3-030-34461-0_18.
LIU Q, GUAN C C, LIU C, et al . Targeting hypoxia-inducible factor-1alpha: a new strategy for triple-negative breast cancer therapy[J ] . Biomed Pharmacother, 2022, 156: 113861. DOI: 10.1016/j.biopha.2022.113861.
YU L, WEI J, LIU P D. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer[J]. Semin Cancer Biol, 2022, 85: 69-94. DOI: 10.1016/j.semcancer.2021.06.019.
WANG X H, XU Y Z, WANG X J, et al . LincRNA-p21 suppresses development of human prostate cancer through inhibition of PKM2[J ] . Cell Prolif, 2017, 50(6): e12395. DOI: 10.1111/cpr.12395.
LI Y, TSANG C K, WANG S H, et al . MAF 1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcription[J ] . Hepatology, 2016, 63(6): 1928-1942. DOI: 10.1002/hep.28507..
TU Z B, HU Y, RAIZADA D, et al . Long noncoding RNA-mediated activation of PROTOR1/PRR5-AKT signaling shunt downstream of PI3K intriple-negative breast cancer[J ] . Proc Natl Acad Sci USA, 2022, 119(43): e2203180119. DOI: 10.1073/pnas.2203180119.
WU X S, WANG F, LI H F, et al . LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis[J ] . EMBO Rep, 2017, 18(10): 1837-1853. DOI: 10.15252/embr.201744147.
A novel estrogen receptor expression stratification (low/moderate/high) based on Chinese population provides more accurate prognosis prediction for HR+/HER2- early breast cancer patients
Mutual regulation of HIF-1α and circ-UBE2G1 under hypoxic microenvironment promotes thyroid cancer metastasis
RANKL通过ROS介导HIF-1α下调促进自噬和破骨细胞分化
Comparison of angiogenetic effects of different dose fractionated radiotherapy on rectal cancer cells
Sulfasalazine antagonizes boosted metastasis of breast cancer induced by ionizing radiation
Related Author
WANG Chengfang
ZHOU Yuqin
ZHANG Yanling
QI Xiaowei
ZHANG Yi
DENG Xiaoling
ZHANG Nengying
LONG Kaiguo
Related Institution
Department of Breast and Thyroid Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Thyroid Breast Surgery, the Second Affiliated Hospital of Zunyi Medical University
Department of Oncology, the First Affiliated Hospital of Chongqing Medical University
State Key Laboratory of Trauma, Burns and Combined Injury, Department of Anti-Radiation Medicine, Chongqing Engineering Research Center for Nanomedicine, Institute of Combined Injury, Faculty of Military Preventive Medicine, Army Medical University (Third Military Medical University)